News

On 23 November, the team within research institute CAPHRI that investigates COVID-19 in nursing homes received the CAPHRI Societal Impact Team Award for the great national and international impact their research has had on the well-being of nursing home residents.

Chlamydia is the most common bacterial sexually transmitted disease (STD) worldwide and in the Netherlands. The clinical and public health relevance of widespread case finding by testing for asymptomatic Chlamydia infections is under debate.

Silvia Evers succeeds Maurice Zeegers as scientific director of CAPHRI as of 1 November 2021.

Prof. dr. Silvia Evers is appointed as scientific director of CAPHRI as of 1 November 2021. She succeeds Prof. dr. Maurice Zeegers.

Astrid van Tubergen has been appointed professor Outcome and innovation in rheumatology practice. She will give her inaugural lecture on 17 September.

The Nationale Wetenschapsagenda (national science agenda) has granted a consortium of 25 other organisations, 1.32 million euro to give children a promising start using big data.

A ZonMw grant has been awarded to the project "Learning platform for guideline development: future-proof and sustainable".

Prof. Paul Savelkoul and Dr. Petra Wolffs (both Medical Microbiology) about their tireless work during the COVID-19 pandemic, and all the other research activities they continue to work on.

The UM research institute GROW and the Maastricht UMC+ Oncology Centre and have together been accredited as a Comprehensive Cancer Centre by the Organisation of European Cancer Institutes (OECI).